Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.2 - $4.98 $358,105 - $810,619
162,775 Added 39.36%
576,354 $1.31 Million
Q1 2024

May 09, 2024

BUY
$2.1 - $4.83 $465,084 - $1.07 Million
221,469 Added 115.28%
413,579 $1.79 Million
Q4 2023

Feb 09, 2024

SELL
$1.12 - $3.73 $13,540 - $45,095
-12,090 Reduced 5.92%
192,110 $585,000
Q3 2023

Nov 13, 2023

BUY
$1.22 - $2.67 $101,112 - $221,286
82,879 Added 68.31%
204,200 $294,000
Q2 2023

Aug 10, 2023

BUY
$2.46 - $3.14 $257,827 - $329,097
104,808 Added 634.7%
121,321 $302,000
Q1 2023

May 09, 2023

BUY
$2.57 - $8.16 $42,438 - $134,746
16,513 New
16,513 $44,000
Q3 2022

Nov 10, 2022

BUY
$5.17 - $16.99 $260,986 - $857,672
50,481 Added 127.29%
90,139 $1.13 Million
Q2 2022

Aug 05, 2022

BUY
$4.04 - $8.51 $160,218 - $337,489
39,658 New
39,658 $196,000
Q4 2021

Feb 10, 2022

SELL
$10.16 - $16.17 $266,303 - $423,831
-26,211 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$13.16 - $22.47 $344,936 - $588,961
26,211 New
26,211 $352,000
Q1 2021

May 13, 2021

SELL
$17.58 - $32.59 $410,141 - $760,324
-23,330 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$10.99 - $20.4 $256,396 - $475,931
23,330 New
23,330 $420,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.